Microbial Sealant Market Report 2026

The microbial sealant market size has grown strongly in recent years. It will grow from $2.81 billion in 2025 to $3.04 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising awareness of surgical site infection prevention, increasing surgical procedure volumes, adoption of standardized preoperative protocols, availability of cyanoacrylate-based medical sealants, growing hospital investments in infection control.

The microbial sealant market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, rising focus on patient safety outcomes, expansion of ambulatory surgical centers, growing adoption in dental and wound care applications, continued innovation in antimicrobial formulations. Major trends in the forecast period include increasing adoption of advanced surgical infection prevention products, growing use of microbial barrier technologies in operating rooms, rising demand for fast-drying and long-lasting sealants, expansion of sealant use across multiple surgical specialties, enhanced focus on reducing surgical site infections.

The rising volume of surgeries is projected to boost the microbial sealant market in the future. Surgery involves a medical procedure where physicians employ instruments to address injuries, diseases, or conditions through incisions into the body or repairs to internal tissues and organs. Surgical procedures are on the rise owing to the higher incidence of chronic diseases that frequently necessitate operative interventions. Microbial sealants aid surgeries by forming a durable barrier on the skin that blocks microbial contamination, thus lowering the risk of surgical site infections and fostering a safer operating environment. For instance, in April 2025, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that public hospitals saw 778,500 admissions from elective surgery waitlists in 2023-24, a 5.8% increase from the 735,500 admissions in 2022-23. Consequently, the growing number of surgeries is fueling expansion in the microbial sealants market.

The rising incidence of sports injuries is anticipated to boost the microbial sealant market in the future. Sports injuries involve physical damage or trauma incurred during sports or recreational pursuits. These injuries are on the rise owing to increased engagement in high-intensity workouts and competitive athletics. Microbial sealants help treat sports injuries by forming an antimicrobial shield over wounds, which lowers the chance of infection and promotes quicker recovery. For instance, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary, reported that ankle injury severity in the English Premier League jumped 170% from October 2022 to January 2023, with calf/shin injuries up 200% and hamstring injuries up 130% after the FIFA World Cup Qatar 2022. Thus, the growing prevalence of sports injuries is fueling expansion in the microbial sealant market.

In July 2023, H.B. Fuller Company, a U.S.-based chemicals manufacturer, acquired Adhezion Biomedical - a U.S.-based medical firm specializing in microbial sealants - for an undisclosed sum, bolstering its position in healthcare adhesives by incorporating cutting-edge cyanoacrylate technologies for surgical applications, wound care, and infection control.

Major companies operating in the microbial sealant market are Johnson & Johnson, Medtronic plc, 3M Company, The Sherwin-Williams Company, Kimberly-Clark Health Care, Becton Dickinson and Company (BD), Evonik Industries AG, Sika AG, B. Braun AG, H.B. Fuller Company, Bostik Inc., Integra LifeSciences Holdings Corporation, Soudal N.V., Technetics Group, Advanced Medical Solutions Group plc, Polymères Technologies Inc., Microban International Ltd., Hodgson Sealants Ltd., Nano-Care Deutschland AG, BioCote Limited.

North America was the largest region in the microbial sealant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbial sealant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial sealant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the microbial sealant market by increasing costs of imported medical-grade polymers, cyanoacrylate compounds, packaging materials, and sterile manufacturing equipment used in sealant production. Hospitals and surgical centers in North America and Europe are most affected due to reliance on specialized imported inputs, while Asia-Pacific faces pricing pressure on export-oriented medical manufacturing. These tariffs are raising procurement costs and affecting supplier pricing strategies. However, they are also encouraging localized production, regional sourcing of raw materials, and increased investment in domestic medical manufacturing capabilities.

The microbial sealant market research report is one of a series of new reports that provides microbial sealant market statistics, including microbial sealant industry global market size, regional shares, competitors with a microbial sealant market share, detailed microbial sealant market segments, market trends and opportunities, and any further data you may need to thrive in the microbial sealant industry. This microbial sealant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A microbial sealant is a liquid medical product that surgeons apply to a patient’s skin prior to surgery. After application, it creates a protective barrier that traps skin flora and stops bacteria from entering the surgical incision, which helps lower the risk of surgical site infections.

Microbial sealants primarily come in two types: natural and synthetic. Natural microbial sealants derive from biological sources like proteins, polysaccharides, and polymers from plants or animals, offering biocompatibility and biodegradability. They include varieties such as ethylene oxide and cyanoacrylate, finding broad use in surgical procedures, wound care, dental care, and more, across settings like hospitals, ambulatory surgical centers, clinics, and others.

The microbial sealant market consists of sales of acrylic polymer sealants, silicone-based sealants, polyurethane sealants, hydrophilic gel sealants, and antimicrobial polymer coatings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.